BioRestorative Therapies files Form 3 initial beneficial ownership statement for director Steven Collier BrownPUBT·21 hours agoBRTX-7.17%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Jul 8 at 04:05 PMAPVO+0.46%BRTX-7.17%
BioRestorative completes Phase 2 manufacturing for BRTX-100 lumbar disc disease trial supplyPUBT·Jun 25 at 07:15 AMBRTX-7.17%
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform | BRTX Stock NewsStockTitan·Jun 24 at 11:15 PMBRTX-7.17%
BioRestorative Therapies files Form 3 for director Jatinder Dhaliwal, reporting no beneficial ownershipPUBT·Jun 18 at 11:40 AMBRTX-7.17%
Zachary Smith appointed VP of Biocosmeceuticals at BioRestorative Therapies to drive growth and expansion.Unusual Whales·Jun 18 at 07:16 AMBRTX-7.17%
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth | BRTX Stock NewsStockTitan·Jun 17 at 11:15 PMBRTX-7.17%
BioRestorative Therapies director Katharyn Field files initial beneficial ownership statementPUBT·Jun 17 at 04:02 PMBRTX-7.17%
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga_article·Jun 4 at 04:05 PMINDP-5.78%BGMS+4.56%
U.S. stock night market opening fluctuations: Biorestorative Therapies fell 9.21% in the night market; Okta rose 7.37% in the night marketPrice Alert·May 28 at 07:22 PMBRTX-7.17%OKTA+1.76%
BioRestorative Therapies shares are trading higher after Kaos Capital announced that it has acquired 4.9% of the issued and outstanding common stock of BioRestorative Therapies.benzinga_article·May 27 at 09:54 AMBRTX-7.17%
